Algert Global’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Algert Global's REGN Position: Q2 2026 in Review
Algert Global opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 786 shares worth $490K. The stake represents 0.01% of the portfolio and ranks #1075 among its holdings. This is a return to the name: Algert Global previously reported a position in REGN as recently as Q4 2025.
Algert Global first reported a position in REGN in Q4 2015 and has held it in 6 quarters since. The position peaked at $923K in Q4 2015. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Algert Global held 786 shares of Regeneron Pharmaceuticals worth $490K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Algert Global position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.01% of Algert Global's portfolio in Q2 2026, its #1075 holding.
- Algert Global first reported a position in Regeneron Pharmaceuticals in Q4 2015 and has held it in 6 quarters since.
- Algert Global's Regeneron Pharmaceuticals position peaked at $923K in Q4 2015.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.